Jing Zhou

发表

Expression of mRNA for type IV collagen α1, α5 and α6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome

A. Michael, M. Gregory, D. Barker, 1998 .

20 – Alport Syndrome and Other Inherited Basement Membrane Disorders

K. Tryggvason, S. L. Hostikka, Jing Zhou, 1993 .

COL4A5 splice site mutation and α5(IV) collagen mRNA in Alport syndrome

K. Tryggvason, U. Frei, O. Pullig, 1993 .

Deletion mapping in Alport syndrome and Alport syndrome‐diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth

D. Barker, R. Nelson, Y. Segal, 2003, Human mutation.

Rapid Publication Identification and Localization of Polycystin , the PKD 1 Gene Product

Y. Pei, H. Rennke, M. Ericsson, 2013 .

Tissue- and developmental stage-specific activation of α5 and α6(IV) collagen expression in the upper gastrointestinal tract of transgenic mice

Y. Segal, L. Zhuang, L. Gorgan, 2003 .

Alport syndrome: a genetic study of 31 families

M. Sanak, C. Bonaiti-Pellié, M. Gubler, 1992, Human Genetics.

Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours

C. Guyot, K. Dahan, K. Leppig, 1995 .

Detection of 12 novel mutations in the collagenous domain of the COL4A5 gene in Alport syndrome patients

M. Bobrow, A. Harris, K. Tryggvason, 1995, Human mutation.

The α Chains of Type IV Collagen

S. Reeders, Jing Zhou, 1996 .

Comparative Distribution of the al ( IV ) , a 5 ( IV ) , and a 6 ( IV ) Collagen Chains in Normal HumanAdult and Fetal Tissues and in Kidneys from X-linked Alport Syndrome Patients

R. Kalluri, H. Rennke, E. Neilson, 2013 .

Tissue- and developmental stage-specific activation of alpha 5 and alpha 6(IV) collagen expression in the upper gastrointestinal tract of transgenic mice.

Y. Segal, L. Zhuang, L. Gorgan, 2003, Biochemical and biophysical research communications.

Deletion spanning the 5′ ends of both the COL4A5 and COL4A6 genes in a patient with Alport's syndrome and leiomyomatosis

A. Ballabio, A. Renieri, M. De Marchi, 1994, Human mutation.

& I k C t i Q I I Of 12 QWB Mutations in the Collagenous Domain of the CQIL./#M Gene in

M. Bobrow, A. Harris, K. Tryggvason, 2005 .

X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.

A. Ballabio, P. Pignatti, G. Rizzoni, 1996, American journal of human genetics.

Identification of mutations in the COL4A5 collagen gene in Alport syndrome.

M. Skolnick, A. Oliphant, M. Gregory, 1990, Science.

LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis.

A. Ballabio, Y. Pei, A. Renieri, 1999, American journal of human genetics.

Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors.

H. Smeets, C. Antignac, A. De Paepe, 1993, Science.

Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome.

M. Gregory, D. Barker, K. Tryggvason, 1991, Genomics.

Regulation of the paired type IV collagen genes COL4A5 and COL4A6. Role of the proximal promoter region.

Y. Segal, J. Zhou, E. Rondeau, 2001, The Journal of biological chemistry.

High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing.

T. Shows, M. Gregory, D. Barker, 1998, Journal of the American Society of Nephrology : JASN.

Structure of the human type IV collagen COL4A5 gene.

K. Tryggvason, J. Zhou, A. Leinonen, 1994, The Journal of biological chemistry.

Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.

C. Antignac, F. Gros, B. Knebelmann, 1994, The Journal of clinical investigation.

Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region.

C. Antignac, C. Antignac, M. Gubler, 1997, Cytogenetics and cell genetics.